SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-250818
Filing Date
2019-09-20
Accepted
2019-09-20 17:27:03
Documents
5
Period of Report
2019-09-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d807008d8k.htm 8-K 21861
2 EX-3.1 d807008dex31.htm EX-3.1 28042
3 EX-3.2 d807008dex32.htm EX-3.2 159879
4 EX-99.1 d807008dex991.htm EX-99.1 5076
5 GRAPHIC g807008g60a35.jpg GRAPHIC 6761
  Complete submission text file 0001193125-19-250818.txt   225582
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 191105482
SIC: 2834 Pharmaceutical Preparations